A systematic review of kidney-on-a-chip-based models to study human renal (patho-)physiology.


Journal

Disease models & mechanisms
ISSN: 1754-8411
Titre abrégé: Dis Model Mech
Pays: England
ID NLM: 101483332

Informations de publication

Date de publication:
01 06 2023
Historique:
received: 30 01 2023
accepted: 04 05 2023
medline: 21 6 2023
pubmed: 19 6 2023
entrez: 19 6 2023
Statut: ppublish

Résumé

As kidney diseases affect ∼10% of the world population, understanding the underlying mechanisms and developing therapeutic interventions are of high importance. Although animal models have enhanced knowledge of disease mechanisms, human (patho-)physiology may not be adequately represented in animals. Developments in microfluidics and renal cell biology have enabled the development of dynamic models to study renal (patho-)physiology in vitro. Allowing inclusion of human cells and combining different organ models, such as kidney-on-a-chip (KoC) models, enable the refinement and reduction of animal experiments. We systematically reviewed the methodological quality, applicability and effectiveness of kidney-based (multi-)organ-on-a-chip models, and describe the state-of-the-art, strengths and limitations, and opportunities regarding basic research and implementation of these models. We conclude that KoC models have evolved to complex models capable of mimicking systemic (patho-)physiological processes. Commercial chips and human induced pluripotent stem cells and organoids are important for KoC models to study disease mechanisms and assess drug effects, even in a personalized manner. This contributes to the Reduction, Refinement and Replacement of animal models for kidney research. A lack of reporting of intra- and inter-laboratory reproducibility and translational capacity currently hampers implementation of these models.

Identifiants

pubmed: 37334839
pii: 316778
doi: 10.1242/dmm.050113
pmc: PMC10309579
pii:
doi:

Types de publication

Systematic Review Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2023. Published by The Company of Biologists Ltd.

Déclaration de conflit d'intérêts

Competing interests The authors declare no competing or financial interests.

Références

Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
Circulation. 2007 Jul 3;116(1):85-97
pubmed: 17606856
Am J Transl Res. 2014 Jan 15;6(2):114-8
pubmed: 24489990
Biotechnol Bioeng. 2016 Oct;113(10):2213-27
pubmed: 27070809
Integr Biol (Camb). 2013 Sep;5(9):1119-29
pubmed: 23644926
ACS Biomater Sci Eng. 2018 Jan 8;4(1):78-89
pubmed: 33418680
Pediatr Nephrol. 2022 Jun;37(6):1245-1261
pubmed: 34389906
Biosens Bioelectron. 2015 Jan 15;63:218-231
pubmed: 25105943
Am J Physiol Renal Physiol. 2021 Oct 1;321(4):F411-F423
pubmed: 34396789
Nat Commun. 2019 Aug 13;10(1):3656
pubmed: 31409793
J Appl Toxicol. 2016 Feb;36(2):330-9
pubmed: 26152902
Lab Chip. 2017 May 16;17(10):1749-1760
pubmed: 28418422
Nephrology (Carlton). 2007 Apr;12(2):155-9
pubmed: 17371339
Cell Tissue Res. 2010 Feb;339(2):449-57
pubmed: 19902259
Curr Opin Organ Transplant. 2015 Apr;20(2):171-7
pubmed: 25856179
Sci Rep. 2019 Mar 15;9(1):4616
pubmed: 30874583
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2293-E2302
pubmed: 28265064
Int J Mol Sci. 2021 May 19;22(10):
pubmed: 34069732
Exp Cell Res. 1997 Oct 10;236(1):248-58
pubmed: 9344605
Integr Biol (Camb). 2011 Feb;3(2):134-41
pubmed: 21079870
Nat Biotechnol. 2019 Mar;37(3):303-313
pubmed: 30833775
Cell. 2006 Aug 25;126(4):663-76
pubmed: 16904174
FASEB J. 2020 May;34(5):6382-6398
pubmed: 32159259
AAPS J. 2018 Jul 23;20(5):86
pubmed: 30039346
Sci Rep. 2016 Aug 25;6:31771
pubmed: 27558173
Lab Chip. 2015 Jun 21;15(12):2688-99
pubmed: 25996126
CPT Pharmacometrics Syst Pharmacol. 2019 May;8(5):316-325
pubmed: 30869201
Sci Rep. 2021 Nov 1;11(1):21356
pubmed: 34725352
Nature. 2015 Oct 22;526(7574):564-8
pubmed: 26444236
Micromachines (Basel). 2021 Aug 19;12(8):
pubmed: 34442605
Lab Chip. 2009 Nov 21;9(22):3185-92
pubmed: 19865724
AAPS J. 2018 Jul 26;20(5):87
pubmed: 30051196
Adv Exp Med Biol. 2019;1165:3-15
pubmed: 31399958
Arch Toxicol. 2021 Jun;95(6):2123-2136
pubmed: 33961089
Kidney Int. 2014 Jun;85(6):1461-8
pubmed: 24522496
ACS Pharmacol Transl Sci. 2020 Jan 28;3(3):496-508
pubmed: 32566915
Nat Biomed Eng. 2020 Apr;4(4):421-436
pubmed: 31988459
Biotechnol Bioeng. 2018 Jun;115(6):1604-1613
pubmed: 29460274
Int J Mol Sci. 2021 Aug 20;22(16):
pubmed: 34445719
Acta Biomater. 2022 Apr 1;142:99-112
pubmed: 35189379
Biomark Insights. 2015 Dec 22;10(Suppl 1):153-69
pubmed: 26740740
AAPS J. 2018 Aug 14;20(5):90
pubmed: 30109442
Micromachines (Basel). 2018 May 10;9(5):
pubmed: 30424161
Biotechnol Prog. 2007 Sep-Oct;23(5):1245-53
pubmed: 17725364
Bull World Health Organ. 2018 Jun 1;96(6):414-422D
pubmed: 29904224
Lab Chip. 2021 Apr 20;21(8):1454-1474
pubmed: 33881130
Am J Physiol Renal Physiol. 2022 Mar 1;322(3):F258-F267
pubmed: 35037466
J Pharm Sci. 2021 Apr;110(4):1601-1614
pubmed: 33545187
J Vis Exp. 2013 Jul 03;(77):e50398
pubmed: 23851420
Front Oncol. 2021 Dec 30;11:762184
pubmed: 35036354
J Am Soc Nephrol. 2013 Oct;24(10):1571-86
pubmed: 24009235
Biomed Microdevices. 2013 Oct;15(5):781-91
pubmed: 23604696
Crit Care Clin. 2021 Apr;37(2):453-474
pubmed: 33752866
Nat Rev Genet. 2022 Aug;23(8):467-491
pubmed: 35338360
Science. 2014 Jul 18;345(6194):1247125
pubmed: 25035496
Front Bioeng Biotechnol. 2020 Nov 12;8:581163
pubmed: 33304889
Tissue Eng Part C Methods. 2021 Mar;27(3):177-182
pubmed: 33544041
Biochim Biophys Acta Gen Subj. 2020 Jan;1864(1):129433
pubmed: 31520681
Proc Soc Exp Biol Med. 1966 Jul;122(3):931-5
pubmed: 5918973
Nat Protoc. 2021 Apr;16(4):2023-2050
pubmed: 33674788
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Trends Pharmacol Sci. 2021 Feb;42(2):119-133
pubmed: 33341248

Auteurs

Vivian V T Nguyen (VVT)

Department of Nephrology and Hypertension, UMC Utrecht, 3584CX Utrecht, The Netherlands.

Vasiliki Gkouzioti (V)

Department of Nephrology and Hypertension, UMC Utrecht, 3584CX Utrecht, The Netherlands.

Christian Maass (C)

esqLABS GmbH, 26683 Saterland, Germany.

Marianne C Verhaar (MC)

Department of Nephrology and Hypertension, UMC Utrecht, 3584CX Utrecht, The Netherlands.

Robin W M Vernooij (RWM)

Department of Nephrology and Hypertension, UMC Utrecht, 3584CX Utrecht, The Netherlands.
Julius Center for Health Sciences and Primary Care, UMC Utrecht, Utrecht University, 3584CX Utrecht, The Netherlands.

Bas W M van Balkom (BWM)

Department of Nephrology and Hypertension, UMC Utrecht, 3584CX Utrecht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH